Literature DB >> 8794334

A vaccinia virus core protein, p39, is membrane associated.

S Cudmore1, R Blasco, R Vincentelli, M Esteban, B Sodeik, G Griffiths, J Krijnse Locker.   

Abstract

We describe herein the characterization of p39, the product of the A4L gene of vaccinia virus. By immunolabelling of thawed cryosections from infected HeLa cells, we show that this protein is initially located in the central region, or viroplasm, of the viral factories, as well as in the immature virions, with very small amounts of labelling observed on the surrounding membranes. The localization of p39 changes dramatically during the transition of the immature virion to the intracellular mature virus (IMV), coincident with the appearance of the core structure in the center of the IMV, with p39 located between this core and the surrounding membranes. Complementary biochemical data, such as partitioning into the Triton X-114 detergent phase and stripping of the viral membranes with Nonidet P-40 and dithiothreitol, suggest that p39 is associated with the innermost of the two membranes surrounding the core. Sodium carbonate treatment also indicates that p39 is associated with membranes, even at the early stages of viral assembly. However, following in vitro translation of p39 in the presence of microsomal membranes, we failed to detect any association of the independently expressed protein with membranes. We also failed to detect any posttranslational acylation of p39 with myristate or palmitate, suggesting that p39 does not achieve its membrane association through lipid anchors. Therefore, p39 is most likely membrane associated through an interaction with an integral membrane protein(s) present in the innermost of the two membranes surrounding the IMV. These data, together with our recent data showing that p39 colocalizes with the spike-like protrusions on the IMV core (N. Roos, M. Cyrklaff, S. Cudmore, R. Blasco, J. Krijnse-Locker, and G. Griffiths, EMBO J. 15:2343-2355, 1996), suggest that p39 may form part of this spike and that it possibly functions as a matrix-like linker protein between the core and the innermost of the two membranes surrounding the IMV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794334      PMCID: PMC190740     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  56 in total

1.  Structural and functional characterization of a cell surface binding protein of vaccinia virus.

Authors:  J S Maa; J F Rodriguez; M Esteban
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

2.  Fusion of intra- and extracellular forms of vaccinia virus with the cell membrane.

Authors:  R W Doms; R Blumenthal; B Moss
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

Review 3.  Regulation of vaccinia virus transcription.

Authors:  B Moss
Journal:  Annu Rev Biochem       Date:  1990       Impact factor: 23.643

4.  Virus attenuation and identification of structural proteins of vaccinia virus that are selectively modified during virus persistence.

Authors:  E Paez; S Dallo; M Esteban
Journal:  J Virol       Date:  1987-08       Impact factor: 5.103

5.  Structural and functional studies of a 39,000-Mr immunodominant protein of vaccinia virus.

Authors:  J S Maa; M Esteban
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

6.  Structure of intracellular mature vaccinia virus observed by cryoelectron microscopy.

Authors:  J Dubochet; M Adrian; K Richter; J Garces; R Wittek
Journal:  J Virol       Date:  1994-03       Impact factor: 5.103

7.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

8.  Fatty acid acylation of vaccinia virus proteins.

Authors:  C A Franke; P L Reynolds; D E Hruby
Journal:  J Virol       Date:  1989-10       Impact factor: 5.103

9.  Biosynthesis and post-translational cleavage of vaccinia virus structural protein VP8.

Authors:  W P Yang; S Y Kao; W R Bauer
Journal:  Virology       Date:  1988-12       Impact factor: 3.616

10.  Monoclonal antibodies identify a group of nuclear pore complex glycoproteins.

Authors:  C M Snow; A Senior; L Gerace
Journal:  J Cell Biol       Date:  1987-05       Impact factor: 10.539

View more
  32 in total

1.  Using confocal microscopy to study virus binding and entry into cells.

Authors:  A Vanderplasschen; G L Smith
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

2.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

3.  Entry of the two infectious forms of vaccinia virus at the plasma membane is signaling-dependent for the IMV but not the EEV.

Authors:  J K Locker; A Kuehn; S Schleich; G Rutter; H Hohenberg; R Wepf; G Griffiths
Journal:  Mol Biol Cell       Date:  2000-07       Impact factor: 4.138

4.  Cell biological and functional characterization of the vaccinia virus F10 kinase: implications for the mechanism of virion morphogenesis.

Authors:  Almira Punjabi; Paula Traktman
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

5.  Vaccinia virus membrane proteins p8 and p16 are cotranslationally inserted into the rough endoplasmic reticulum and retained in the intermediate compartment.

Authors:  T Salmons; A Kuhn; F Wylie; S Schleich; J R Rodriguez; D Rodriguez; M Esteban; G Griffiths; J K Locker
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

Review 6.  A guide to viral inclusions, membrane rearrangements, factories, and viroplasm produced during virus replication.

Authors:  Christopher Netherton; Katy Moffat; Elizabeth Brooks; Thomas Wileman
Journal:  Adv Virus Res       Date:  2007       Impact factor: 9.937

7.  Myxoma and vaccinia viruses bind differentially to human leukocytes.

Authors:  Winnie M Chan; Eric C Bartee; Jan S Moreb; Ken Dower; John H Connor; Grant McFadden
Journal:  J Virol       Date:  2013-02-06       Impact factor: 5.103

8.  Structure and assembly of intracellular mature vaccinia virus: isolated-particle analysis.

Authors:  G Griffiths; R Wepf; T Wendt; J K Locker; M Cyrklaff; N Roos
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

9.  Fine structure of the vaccinia virion determined by controlled degradation and immunolocalization.

Authors:  Nissin Moussatche; Richard C Condit
Journal:  Virology       Date:  2014-12-08       Impact factor: 3.616

10.  The Vaccinia virus E8R gene product: a viral membrane protein that is made early in infection and packaged into the virions' core.

Authors:  Laura Doglio; Ario De Marco; Sibylle Schleich; Norbert Roos; Jacomine Krijnse Locker
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.